T1	Participants 32 78	Collaborative Initial Glaucoma Treatment Study
T2	Participants 444 496	Six hundred seven newly diagnosed glaucoma patients.
T3	Participants 537 590	607 subjects with newly diagnosed open-angle glaucoma
T4	Participants 1806 1848	subjects with advanced VF loss at baseline
T5	Participants 1858 1880	subjects with diabetes
T6	Participants 2213 2264	subjects with more advanced VF loss at presentation
T7	Participants 2286 2308	patients with diabetes
